Figure 3
![Figure 3. Characterization of P2X1 activation at the surface of PMNs. (A-B) Expression of CD11b (A), CD11b, CD18, and CD62L (B) at the surface of human PMNs (the gate of PMNs were based on their size (Side Scatter [SS]) and their granulometry (Forward Scatter [FS]) challenged with 10 μM ATP and 0.5 μM phorbol myristate acetate (PMA) (A) or 10 μM α, β-meATP, and 200 U/ml TNF-α (B), (n = 10, *P < .05).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/124/16/10.1182_blood-2014-04-571679/4/2575f3.jpeg?Expires=1722693278&Signature=FscBQUg9HW8iDbVFe0OWpvx1l9VjfevCsmyKBFuiJ86rxv1QGTV9IXbYkPNoTjFx1JhDWaJvI4B6EzK1uf8YyP2w1cw9UTilOkwU~3M2PjOWMgVW4B32ap4k68aos~W-6FdEjYSQRbmcx5N1Cs5nMK9YDAmW~RnsRDaiMP43xR69kaMQ0o8TcF~u2P3TTSsXgyy81eP-Sa-iI8QVCqpEgqX6xWHZSOBCzHaVR496mtN3byIriVa4OYfjyCCfYZcjSyg25xCc6DHQ1zfbg6m9vD9DGbG4cwZWNgQ1U4x2ftO9JxoBzPYhG4RxowhYZ2Z51B41fclLnPgF5zHvwL~bMA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Characterization of P2X1 activation at the surface of PMNs. (A-B) Expression of CD11b (A), CD11b, CD18, and CD62L (B) at the surface of human PMNs (the gate of PMNs were based on their size (Side Scatter [SS]) and their granulometry (Forward Scatter [FS]) challenged with 10 μM ATP and 0.5 μM phorbol myristate acetate (PMA) (A) or 10 μM α, β-meATP, and 200 U/ml TNF-α (B), (n = 10, *P < .05).
